Generex Biotechnology acquires Medisource Partners
Canadian firm Generex Biotechnology has acquired Texas-based medical and surgical products distributor Medisource Partners.
Under the terms of the deal Generex will own all of Medisource’s assets in an all-stock transaction effective 1 August 2019.
Medisource CEO Travis Bird commented: “In the last decade, MediSource has established itself as a service-focused, ‘one stop shop’ for the physicians, surgeons, and healthcare professionals we serve.
“With a broad catalogue of surgical supplies, orthopedic implants, and a wide portfolio of biologics and Cellular and Tissue Products (CTPs), we are excited to become part of Generex and the NuGenerex family of companies as we work together to bring innovative and effective treatments, therapies, and products to the MSO network.
“As demonstrated by this all stock transaction, I believe in the Generex vision and look forward to being an essential part of our future growth.”
Generex CEO Joe Moscato added: “The strategic acquisition of Medisource Partners provides Generex with a value-added service model that fits the corporate mission of NuGenerex Distribution Solutions, adding immediate revenues and profits, while providing significant upside as we integrate the medical and surgical supply business into our current and future MSO networks.
The technological pharmaceutical company IMIDEX has been granted clearance from the US Food and Drug …
On 16 August 2023, the US Food and Drug Administration (FDA) officially cleared Artiva Biotherapeutics’ …